Top Five Articles on 360Dx Last Week: Opposition to FDA LDT Proposal; Natera, Invitae Deal, More

NEW YORK – What were the articles that gained the most interest from 360Dx readers last week? Here are the top five:

1) Labs, Providers Strongly Oppose FDA LDT Proposed Rule in Public Comments

2) Natera Acquires Reproductive Health Assets From Invitae for up to $52.5M

3) Japanese Researchers Develop One-Minute Bioluminescent COVID-19 Test

4) With Expanded FDA Clearance for Sepsis Test, Immunexpress Furthers Commercialization Strategy

5) DiaSorin Submits Lyme Disease Test for FDA Approval